News

The initial three-year term contract has been extended to five years, which will cover sites in the US, Canada, Mexico, Brazil, China, and Singapore, and comes after the

With the continuation of commercial availability until the end of 2013, the temporary suspension was based on the German Federal Joint Committee’s (G-BA) decision on drug’s additional benefits

Commenting on the expansion, Cromos managing director Dr Andrey Tarakanov said, "The staff of our Smolensk office has considerable experience in all stages of clinical trial conduct in

Scheduled to enroll a minimum of 48 patients from Asia Pacific geographies, the multicenter, placebo-controlled, double-blind study will randomize the subjects into one active treatment arm or one

Leveraging an asset management approach, the new software improves cooperation and provides the automation of documents used throughout the drug product life cycle, from pre-clinical through product registration

The Supplemental New Drug Application (sNDA) of Mycamine is also indicated for patients with prophylaxis of Candida infections in patients undergoing hematopoietic stem cell transplants (HSCT). Astellas Pharma

Offered through the company’s existing wholesaler and pharmacy channels, the generic product that is indicated for erectile dysfunction in adult men had already been launched in Spain, Canada

Albiglutide is an investigational glucagon-like peptide receptor agonist (GLP-1), which is an investigational once a week treatment for type 2 diabetes. Comprising eight individual studies (Harmony 1 to

Under the terms of the agreement, ADC Therapeutics has licensed a VivaMab antibody, VM101, produced using BioAtla’s Express Humanization, Comprehensive Positional Evolution, Combinatorial Protein Synthesis affinity and functional